New study 2020

Long-term effects of the treatment of acute lymphoblastic leukemia (ALL) in paediatric patients


With current treatments, the survival rate of children with ALL is now 85%. Despite this good prognosis, the long-term side effects of treatments can affect the future quality of life of patients.


Identify and analyze the side effects of treatment 3 years after remission of ALL, taking into account the perspective of patients with pediatric disease onset (or that of their caregivers) as a source of information.


A clinical and psychosocial study that will use the information provided directly by patients and their caregivers through the use of a validated ALAN scale (Acute Leukaemia Advocates Network) to report quality of life data. This pilot will be carried out in collaboration with the CLOSER project (GA 825749) and will also collect information from patients in Argentina, Chile and Uruguay.

Research is the heart of Share4Rare. By working together we can help to advance the research efforts in rare diseases. That's why we need you: join the community and participate in research!

Step 1

Join Share4Rare!

A valid email address. All emails from the system will be sent to this address. The email address is not made public and will only be used if you wish to receive a new password or wish to receive certain news or notifications by email.
Several special characters are allowed, including space, period (.), hyphen (-), apostrophe ('), underscore (_), and the @ sign.

Due to EU regulations, this platform is accessible only by users over 18 years old

Disease you are related to
Drag to re-order
Do you belong to any patients' registry?
Please, read carefully the Share4Rare terms of use and privacy policy.